TF and renal cell carcinoma: We further characterize the downstream consequences of TF binding disruption at GWAS significant RCC loci by leveraging the largest available plasma proteomic data from the UK Biobank, identifying sets of proteins trans-regulated by altered TF binding, highlighting downstream targets for each TF.